BG34181A3 - Method for obtaining antigene patent medicine - Google Patents

Method for obtaining antigene patent medicine

Info

Publication number
BG34181A3
BG34181A3 BG034303A BG3430376A BG34181A3 BG 34181 A3 BG34181 A3 BG 34181A3 BG 034303 A BG034303 A BG 034303A BG 3430376 A BG3430376 A BG 3430376A BG 34181 A3 BG34181 A3 BG 34181A3
Authority
BG
Bulgaria
Prior art keywords
antigenic protein
antigene
obtaining
patent medicine
microvesicles
Prior art date
Application number
BG034303A
Other languages
Bulgarian (bg)
English (en)
Inventor
June Almeida
David Edwards
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG34181A3 publication Critical patent/BG34181A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BG034303A 1975-09-29 1976-09-28 Method for obtaining antigene patent medicine BG34181A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39857/75A GB1564500A (en) 1975-09-29 1975-09-29 Biological preparations

Publications (1)

Publication Number Publication Date
BG34181A3 true BG34181A3 (en) 1983-07-15

Family

ID=10411873

Family Applications (1)

Application Number Title Priority Date Filing Date
BG034303A BG34181A3 (en) 1975-09-29 1976-09-28 Method for obtaining antigene patent medicine

Country Status (15)

Country Link
JP (1) JPS5244228A (de)
AU (1) AU514848B2 (de)
BE (1) BE846681A (de)
BG (1) BG34181A3 (de)
CA (1) CA1079634A (de)
DD (1) DD127598A5 (de)
DE (1) DE2643641A1 (de)
ES (1) ES451923A1 (de)
FR (1) FR2325387A1 (de)
GB (1) GB1564500A (de)
HU (1) HU176180B (de)
NL (1) NL7610736A (de)
PL (1) PL103082B1 (de)
SE (1) SE7610708L (de)
ZA (1) ZA765817B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
US4196191A (en) 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4201767A (en) * 1978-11-08 1980-05-06 Merck & Co., Inc. Viral liposome particle
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
FR2543018B1 (fr) * 1983-03-22 1985-07-26 Oreal Procede de preparation de vesicules lipidiques par vaporisation de solvants
IT1238343B (it) * 1989-10-16 1993-07-13 Cesalpino Andrea Fond Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche
RU94040856A (ru) * 1992-03-03 1996-08-20 Дайити Фармасьютикал Ко. Вакцина для перорального введения
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
AU2014368594B2 (en) * 2013-12-19 2020-03-05 Janssen Vaccines & Prevention B.V. Improved formulations for virosomes

Also Published As

Publication number Publication date
DD127598A5 (de) 1977-10-05
JPS5244228A (en) 1977-04-07
CA1079634A (en) 1980-06-17
ZA765817B (en) 1978-05-30
AU1816476A (en) 1978-04-06
GB1564500A (en) 1980-04-10
BE846681A (fr) 1977-03-28
SE7610708L (sv) 1977-03-30
FR2325387A1 (fr) 1977-04-22
PL103082B1 (pl) 1979-05-31
ES451923A1 (es) 1977-08-16
DE2643641A1 (de) 1977-04-14
AU514848B2 (en) 1981-03-05
HU176180B (en) 1980-12-28
FR2325387B1 (de) 1980-06-27
NL7610736A (nl) 1977-03-31

Similar Documents

Publication Publication Date Title
BG34181A3 (en) Method for obtaining antigene patent medicine
SE7613241L (sv) Serologiskt forfarande for bestemning av neisseria gonorrhoeae-antikroppar
ZA763627B (en) Preparation of aqueous soy protein
BG31497A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортонизамиди
FR2322373A1 (fr) Methode et necessaire de dosage immunologique d'un antigene en phase solide
BG25090A3 (bg) Метод за получаване на 5,9-бета-заместени -2-тетрахидрофурфурил- 6,7-бензоморфани и техните соли
BG24814A4 (bg) Метод за получаване на 2-тетрахидрофурфурил-6,7 бензоморфани и техните соли
ATA162876A (de) Verfahren zur herstellung von neuen piperazinyliminorifamycinen
AT350748B (de) Verfahren zur herstellung von neuen d-17alpha- aethinyl-17beta-acyloxy-19-nortestosteron-3- oximen
FR2326205A1 (fr) Methode pour detecter des antigenes et anticorps de l'hepatite et vaccin contre l'hepatite
BG27546A4 (bg) Метод за получаване на n-тетрахидрофурил-порокси-морфини и техни соли
IL49459A (en) Gonococcal pilin and other materials isolated from pili of neisseria gonorrhoeae compositions and vaccines containing them and method of testing the presence of antibodies to n. gonorrhoeae pili
NL7605016A (nl) Schokvast polystyreenmengsel en werkwijze ter bereiding daarvan.
BE841867A (fr) Perfectionnements a la preparation des matieres proteiques
ATA669876A (de) Verfahren zur herstellung von neuen derivaten des 1,2,4-oxadiazin-5-ons
IT1128549B (it) Composizione antigene relativo vaccino e procedimento di produzione
USD234525S (en) Stuffed toy
AT344698B (de) Verfahren zur herstellung von neuen n4-substituierten 5-phenyl-1,3,4,5-tetrahydro-2h-1,4-benzodiazepin-2-on-derivaten
SU531882A1 (ru) Способ подготовки шихты дл получени марганцевых сплавов
AT347452B (de) Verfahren zur herstellung von neuen 1- thiadiazolyl-5-acyloxy-imidazolidin-2-onen
DD138983A1 (de) Verfahren zur herstellung von neuen n-funktionellen cardenolidderivaten
NL7609901A (nl) Permanentmagnetisch, overwegend ceriummengme- taal (cemm)- en kobalthoudend materiaal en werk- wijze voor de vervaardiging daarvan.
AT348988B (de) Verfahren zur herstellung von neuen alkylol- amiden jodierbarer aminosaeuren
ATA376876A (de) Verfahren zur herstellung von neuen derivaten des 1-hydroxybenzo-2,3,1-diazaborins
ATA976775A (de) Verfahren zur herstellung von neuen n-benzoyl-n-phenyl-sulfensaureamiden